Startup profile · funding coverage
Cardiogram funding, valuation and investors
Apple Watch and wearable analytics for heart health and arrhythmia detection.
Keep track of Cardiogram
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$2M · October 2016
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$2M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
acquired
acquired
Investors in latest funding
Lead: Andreessen Horowitz
Overview
Cardiogram analyzed Apple Watch and wearable heart-rate data using its DeepHeart neural network for arrhythmia and cardiovascular risk signals. a16z Bio led a $2M seed in 2016. ilumivu acquired Cardiogram in October 2021, continuing cardiovascular monitoring capabilities.
Why Cardiogram is interesting
Cardiogram's DeepHeart neural net turned consumer wearables into cardio screening tools — a16z Bio led seed before ilumivu acquired it in 2021.
Product & use cases
Wearable analytics app using DeepHeart ML on Apple Watch data for heart health and arrhythmia screening.
- Consumer heart rhythm monitoring via Apple Watch
- Atrial fibrillation detection research workflows
- Wearable-derived cardio risk signals
Key facts
- Acquired by ilumivu (Oct 2021): cardiovascular monitoring app (PR Newswire)
- Seed (Oct 2016): $2M led by a16z Bio; Homebrew angels participated (TechCrunch)
- Co-investors: no additional institutional investors disclosed in public sources reviewed 2026-07-24
- Source: https://techcrunch.com/2016/10/20/cardiogram-raises-2-million-to-predict-heart-health-issues-using-wearbles/
Funding history (newest first)
Investors in our directory
Funds linked from Cardiogram's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Cardiogram differentiates through focused product scope and a16z-backed GTM in its category — see competitors for tradeoffs vs. incumbents.
Cardiogram operates in a competitive category where incumbents have distribution but startups win on workflow fit. See named competitors for honest better/worse notes; we do not invent market share.
-
Apple Health incumbent
Native AFib notifications; Cardiogram added research-grade analytics.
-
Fitbit/Google adjacent
Wearable ecosystem competitor set.
Notable stories
- Acquired by ilumivu (Oct 2021): cardiovascular monitoring app (PR Newswire)
- Seed (Oct 2016): $2M led by a16z Bio; Homebrew angels participated (TechCrunch)
Industries
Related funding articles
Venture Capital Tracker pieces that cover Cardiogram's financing or category context.
FAQs about Cardiogram
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.